Sanofi India: The unaudited financial results for the quarter and nine months ended 30th September 2026
Sanofi India (SANOFI) filed a disclosure titled "The unaudited financial results for the quarter and nine months ended 30th September 2026". The company is valued at about ₹7,346 crore.
What happened
Sanofi India (SANOFI) filed a disclosure with the exchanges on 29 October 2026 at 06:28 PM titled "The unaudited financial results for the quarter and nine months ended 30th September 2026".
From the filing: "Sanofi India Limited has submitted to the Exchange, the unaudited financial results for the quarter and nine months ended 30th September 2026."
Company snapshot
Sanofi India is a small-cap company, with a market value of about ₹7,346 crore.
The stock last traded at ₹3,189.5, against a 52-week range of ₹2,758.2–₹4,898 (34.9% below the high).
Before this filing the shares had moved −4.7% over the month and −12.5% over three months. Average daily turnover over the last 20 sessions was about ₹4.51 crore.
Promoters held 60.40% at the end of Q1 FY27. Foreign institutions owned 5.69% and domestic institutions 19.87%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 406 | 69.5 | 30.18 |
| Q2 FY26 | 475 | 76 | 32.99 |
| Q3 FY26 | 420 | 61.7 | 26.79 |
| Q4 FY26 | 472 | 102.6 | 44.55 |
| Q1 FY27 | 438 | 83.5 | 36.26 |
What history shows
This is not the company's first results disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
Market-wide, 9,836 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 29 October 2026: Board meeting — Financial Results/Dividend.
In the news
Recent coverage elsewhere (links open the original publisher):
- Sanofi (SNY) stock price, news, quote and history
- Sanofi Consumer share price jumps 11% after strong Q3 results | Is it time to book profits? Check target, rationale
- Sanofi Consumer Q3 Profit Rises to ₹76.6 Cr; Revenue Up 13%
- Sanofi Consumer Healthcare India Sept-Quarter Profit 766 Million Rupees
- Sanofi shares may move 4.3% on Oct. 30 earnings release
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.